Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Tilray Brands, Inc.NASDAQ: TLRY

EPS (Basic) · Q3 FY2026 · quarter ended Feb 2026

EPS (Basic) remains negative

Q3 FY2026 EPS (Basic) was -$0.33, compared with -$12.6 a year earlier. Trailing-twelve-month EPS (Basic) was -$18.7.

Context

  • EPS (Basic) grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 3 analysts of -$0.64 (+98.1%) for the fiscal year ending May 2026, a step up from the -651.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$0.33+42.1% QoQ
Last fiscal yearMay 2025
-$33.8-651.1% YoY
LTMFeb 2026
-$18.7-23.9% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+97.4%+100.0%+2.6 pp
1 year-651.1%+98.1%+749.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(33.80) USD
Year-over-year change
-651.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -23.9% is the 2nd highest of 3, against a peer median of -2791.4%.
TLRY Competitors
EPS (Basic) for TLRY and competitors
Company Period LTM YoY 3-year CAGR
SNDLSNDL Inc.LTM Mar 2026-CA$0.05 CAD+86.9%—
ACBAurora Cannabis Inc.LTM Mar 2026-CA$2.23 CAD-5669.8%—
TLRYTilray Brands, Inc.LTM Feb 2026-$18.7 USD-23.9%—
GLASGlass House Brands Inc—— ——
Peer median (excluding TLRY) —-2791.4%—

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue619.67M792.12M844.72M1.07B1.13B
Cost of Revenue470.9M644.86M646.77M770.66M796.88M
Gross Profit148.77M147.26M197.95M304.33M330.11M
Gross Margin24.0%18.6%23.4%28.3%29.3%
Research & Development1M1.91M918.64K865.23K389.7K
Selling, General & Admin188.03M233.38M311.13M341.63M356.06M
Operating Expenses308.4M916.72M2.04B542.43M3.46B
Depreciation & Amortization81.92M194.88M175.31M172.93M183.17M
EBITDA(297.41M)(310.61M)(1.72B)(99.25M)(2.92B)
EBITDA Margin-48.0%-39.2%-203.1%-9.2%-259.0%
Operating Income(159.63M)(769.46M)(1.84B)(238.1M)(3.13B)
Operating Margin-25.8%-97.1%-218.4%-22.1%-277.9%
Interest Income3.53M14.79M44.48M17.48M15.61M
Interest Expense37.32M50.02M62.79M67.13M56.71M
Other Income / Expenses(257.02M)213.96M(108.43M)(101.2M)(26.99M)
Income Before Tax(416.65M)(555.51M)(1.95B)(339.31M)(3.16B)
Pre-Tax Margin-67.2%-70.1%-231.2%-31.6%-280.3%
Income Tax Expense(10.84M)(8.25M)(9.67M)(36.27M)(166.06M)
Net Income(443.75M)(601.05M)(1.96B)(333.8M)(3B)
Net Margin-71.6%-75.9%-231.6%-31.1%-266.3%
EPS (Basic)(13.61)(9.94)(31.70)(4.50)(33.80)
EPS (Diluted)(13.61)(9.94)(31.70)(4.50)(33.80)
Weighted Avg Shares26.95M48.12M61.8M74.26M89.03M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M89.03M

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.